NO781051L - Kinazolinderivater. - Google Patents

Kinazolinderivater.

Info

Publication number: NO781051L
Authority: NO; Norway
Prior art keywords: formula; compounds; compound; pyrido; lower alkyl
Prior art date: 1977-03-24

Application number

NO781051A

Other languages

English (en)

Norwegian (no)

Inventor

Richard Wightman Kierstead

Jefferson Wright Tilley

Original Assignee

Hoffmann La Roche

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1977-03-24

Filing date

1978-03-22

Publication date

1978-09-26

1978-03-22 Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche

1978-09-26 Publication of NO781051L publication Critical patent/NO781051L/no

Links

150000001875 compounds Chemical class 0.000 claims description 89
238000000034 method Methods 0.000 claims description 38
125000000217 alkyl group Chemical group 0.000 claims description 32
-1 cyano, 5-tetrazolyl Chemical group 0.000 claims description 32
229910052739 hydrogen Inorganic materials 0.000 claims description 31
239000001257 hydrogen Substances 0.000 claims description 31
125000003545 alkoxy group Chemical group 0.000 claims description 20
239000000203 mixture Substances 0.000 claims description 17
150000003839 salts Chemical class 0.000 claims description 16
239000002253 acid Substances 0.000 claims description 15
150000002431 hydrogen Chemical class 0.000 claims description 15
238000002360 preparation method Methods 0.000 claims description 14
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 12
229910052736 halogen Inorganic materials 0.000 claims description 11
150000002367 halogens Chemical class 0.000 claims description 11
239000007787 solid Substances 0.000 claims description 10
UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical compound [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 claims description 9
125000002252 acyl group Chemical group 0.000 claims description 9
229910002091 carbon monoxide Inorganic materials 0.000 claims description 9
239000002585 base Substances 0.000 claims description 8
BPZOBPJZRALKPI-UHFFFAOYSA-N 11-oxo-8-propan-2-ylpyrido[2,1-b]quinazoline-2-carboxylic acid Chemical class C1=C(C(O)=O)C=C2C(=O)N(C=C(C(C)C)C=C3)C3=NC2=C1 BPZOBPJZRALKPI-UHFFFAOYSA-N 0.000 claims description 6
QBEIZCZOJLXENV-UHFFFAOYSA-N 9h-pyrido[2,1-b]quinazoline Chemical class C1=CC=CC2=CN3CC=CC=C3N=C21 QBEIZCZOJLXENV-UHFFFAOYSA-N 0.000 claims description 6
239000012298 atmosphere Substances 0.000 claims description 6
HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 6
229910052759 nickel Inorganic materials 0.000 claims description 6
PXHVJJICTQNCMI-UHFFFAOYSA-N nickel Substances [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 claims description 6
NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 claims description 5
ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims description 4
YRJDGHURCRQXTP-UHFFFAOYSA-N 8-methyl-11-oxopyrido[2,1-b]quinazoline-2-carboxylic acid Chemical compound C1=C(C(O)=O)C=C2C(=O)N(C=C(C)C=C3)C3=NC2=C1 YRJDGHURCRQXTP-UHFFFAOYSA-N 0.000 claims description 4
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 4
229920000881 Modified starch Polymers 0.000 claims description 4
229910052783 alkali metal Inorganic materials 0.000 claims description 4
GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 4
229910052794 bromium Inorganic materials 0.000 claims description 4
125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 4
239000008101 lactose Substances 0.000 claims description 4
150000007530 organic bases Chemical group 0.000 claims description 4
WKJSXVIGMWOVGG-UHFFFAOYSA-N 2-(diethylamino)ethyl 11-oxo-8-propan-2-ylpyrido[2,1-b]quinazoline-2-carboxylate Chemical compound C1=CC(C(C)C)=CN2C(=O)C3=CC(C(=O)OCCN(CC)CC)=CC=C3N=C21 WKJSXVIGMWOVGG-UHFFFAOYSA-N 0.000 claims description 3
WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 3
239000004480 active ingredient Substances 0.000 claims description 3
150000001350 alkyl halides Chemical class 0.000 claims description 3
238000013459 approach Methods 0.000 claims description 3
239000002775 capsule Substances 0.000 claims description 3
DOBRDRYODQBAMW-UHFFFAOYSA-N copper(i) cyanide Chemical compound [Cu+].N#[C-] DOBRDRYODQBAMW-UHFFFAOYSA-N 0.000 claims description 3
230000007062 hydrolysis Effects 0.000 claims description 3
238000006460 hydrolysis reaction Methods 0.000 claims description 3
XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 claims description 3
239000011630 iodine Substances 0.000 claims description 3
229910052740 iodine Inorganic materials 0.000 claims description 3
PELJISAVHGXLAL-UHFFFAOYSA-N iodomethyl 2,2-dimethylpropanoate Chemical group CC(C)(C)C(=O)OCI PELJISAVHGXLAL-UHFFFAOYSA-N 0.000 claims description 3
235000019359 magnesium stearate Nutrition 0.000 claims description 3
238000002156 mixing Methods 0.000 claims description 3
239000004368 Modified starch Substances 0.000 claims description 2
238000006136 alcoholysis reaction Methods 0.000 claims description 2
125000001246 bromo group Chemical group Br* 0.000 claims description 2
125000004093 cyano group Chemical group *C#N 0.000 claims description 2
230000032050 esterification Effects 0.000 claims description 2
238000005886 esterification reaction Methods 0.000 claims description 2
150000005748 halopyridines Chemical class 0.000 claims description 2
235000019426 modified starch Nutrition 0.000 claims description 2
239000000546 pharmaceutical excipient Substances 0.000 claims description 2
239000007916 tablet composition Substances 0.000 claims description 2
125000002887 hydroxy group Chemical group [H]O* 0.000 claims 7
230000003266 anti-allergic effect Effects 0.000 claims 2
239000013543 active substance Substances 0.000 claims 1
125000003282 alkyl amino group Chemical group 0.000 claims 1
238000005915 ammonolysis reaction Methods 0.000 claims 1
239000000969 carrier Substances 0.000 claims 1
125000001309 chloro group Chemical group Cl* 0.000 claims 1
239000007788 liquid Substances 0.000 claims 1
238000004519 manufacturing process Methods 0.000 claims 1
231100000252 nontoxic Toxicity 0.000 claims 1
230000003000 nontoxic effect Effects 0.000 claims 1
125000003790 chinazolinyl group Chemical group 0.000 abstract 1
ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 33
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 21
239000000243 solution Substances 0.000 description 18
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 15
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 15
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 12
238000002425 crystallisation Methods 0.000 description 12
230000008025 crystallization Effects 0.000 description 12
NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 12
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
239000011541 reaction mixture Substances 0.000 description 9
238000006243 chemical reaction Methods 0.000 description 7
238000001816 cooling Methods 0.000 description 7
125000004356 hydroxy functional group Chemical group O* 0.000 description 7
239000003921 oil Substances 0.000 description 7
239000000047 product Substances 0.000 description 7
239000002904 solvent Substances 0.000 description 7
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
OKXPYKHKJCATPX-UHFFFAOYSA-N quinazoline-2-carboxylic acid Chemical compound C1=CC=CC2=NC(C(=O)O)=NC=C21 OKXPYKHKJCATPX-UHFFFAOYSA-N 0.000 description 6
CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 5
QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 5
AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 5
239000000920 calcium hydroxide Substances 0.000 description 5
229910001861 calcium hydroxide Inorganic materials 0.000 description 5
125000001589 carboacyl group Chemical group 0.000 description 5
239000000725 suspension Substances 0.000 description 5
JLHGXOFXIAHWPC-UHFFFAOYSA-N 2-(6-chloropyridin-3-yl)propan-2-ol Chemical compound CC(C)(O)C1=CC=C(Cl)N=C1 JLHGXOFXIAHWPC-UHFFFAOYSA-N 0.000 description 4
QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 4
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 4
UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
239000002552 dosage form Substances 0.000 description 4
239000000706 filtrate Substances 0.000 description 4
238000001914 filtration Methods 0.000 description 4
239000012442 inert solvent Substances 0.000 description 4
238000012360 testing method Methods 0.000 description 4
FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 4
HMZDSBSMNLBGIW-UHFFFAOYSA-N 11-oxopyrido[2,1-b]quinazoline-2-carboxylic acid Chemical compound C1=CC=CN2C(=O)C3=CC(C(=O)O)=CC=C3N=C21 HMZDSBSMNLBGIW-UHFFFAOYSA-N 0.000 description 3
CUKXRHLWPSBCTI-UHFFFAOYSA-N 2-amino-5-bromobenzoic acid Chemical compound NC1=CC=C(Br)C=C1C(O)=O CUKXRHLWPSBCTI-UHFFFAOYSA-N 0.000 description 3
DOWUDFBDZHHIBG-UHFFFAOYSA-N 2-bromopyrido[2,1-b]quinazolin-11-one;hydrochloride Chemical compound Cl.C1=CC=CN2C(=O)C3=CC(Br)=CC=C3N=C21 DOWUDFBDZHHIBG-UHFFFAOYSA-N 0.000 description 3
QZBFXTKTUZYMRW-UHFFFAOYSA-N 2-chloro-5-prop-1-en-2-ylpyridine Chemical compound CC(=C)C1=CC=C(Cl)N=C1 QZBFXTKTUZYMRW-UHFFFAOYSA-N 0.000 description 3
DNJROFGCOSDKIL-UHFFFAOYSA-N 2-chloro-5-propan-2-ylpyridine Chemical compound CC(C)C1=CC=C(Cl)N=C1 DNJROFGCOSDKIL-UHFFFAOYSA-N 0.000 description 3
YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 3
KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
241000700159 Rattus Species 0.000 description 3
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
238000009835 boiling Methods 0.000 description 3
239000008120 corn starch Substances 0.000 description 3
238000004821 distillation Methods 0.000 description 3
150000002825 nitriles Chemical group 0.000 description 3
238000010992 reflux Methods 0.000 description 3
FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 3
238000003756 stirring Methods 0.000 description 3
239000008096 xylene Substances 0.000 description 3
MQZHXWASCRSHMN-UHFFFAOYSA-N 11-oxo-8-propan-2-ylpyrido[2,1-b]quinazoline-2-carbonitrile Chemical compound C1=C(C#N)C=C2C(=O)N(C=C(C(C)C)C=C3)C3=NC2=C1 MQZHXWASCRSHMN-UHFFFAOYSA-N 0.000 description 2
YDVVDTQDDKPUDO-UHFFFAOYSA-N 2-(diethylamino)ethyl 11-oxo-8-propan-2-ylpyrido[2,1-b]quinazoline-2-carboxylate;hydrochloride Chemical compound Cl.C1=CC(C(C)C)=CN2C(=O)C3=CC(C(=O)OCCN(CC)CC)=CC=C3N=C21 YDVVDTQDDKPUDO-UHFFFAOYSA-N 0.000 description 2
VTPICOKAXVHMEF-UHFFFAOYSA-N 2-bromo-8-propan-2-ylpyrido[2,1-b]quinazolin-11-one Chemical compound C1=C(Br)C=C2C(=O)N(C=C(C(C)C)C=C3)C3=NC2=C1 VTPICOKAXVHMEF-UHFFFAOYSA-N 0.000 description 2
NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
229920002261 Corn starch Polymers 0.000 description 2
ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 2
IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 2
AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
150000007513 acids Chemical class 0.000 description 2
150000001408 amides Chemical class 0.000 description 2
229910021529 ammonia Inorganic materials 0.000 description 2
RWZYAGGXGHYGMB-UHFFFAOYSA-N anthranilic acid Chemical compound NC1=CC=CC=C1C(O)=O RWZYAGGXGHYGMB-UHFFFAOYSA-N 0.000 description 2
229910052786 argon Inorganic materials 0.000 description 2
208000006673 asthma Diseases 0.000 description 2
125000004432 carbon atom Chemical group C* 0.000 description 2
239000007795 chemical reaction product Substances 0.000 description 2
239000012043 crude product Substances 0.000 description 2
NPOMSUOUAZCMBL-UHFFFAOYSA-N dichloromethane;ethoxyethane Chemical compound ClCCl.CCOCC NPOMSUOUAZCMBL-UHFFFAOYSA-N 0.000 description 2
239000003814 drug Substances 0.000 description 2
229940079593 drug Drugs 0.000 description 2
150000002148 esters Chemical class 0.000 description 2
239000012065 filter cake Substances 0.000 description 2
208000030603 inherited susceptibility to asthma Diseases 0.000 description 2
KJIFKLIQANRMOU-UHFFFAOYSA-N oxidanium;4-methylbenzenesulfonate Chemical compound O.CC1=CC=C(S(O)(=O)=O)C=C1 KJIFKLIQANRMOU-UHFFFAOYSA-N 0.000 description 2
XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 2
238000011321 prophylaxis Methods 0.000 description 2
239000000454 talc Substances 0.000 description 2
229910052623 talc Inorganic materials 0.000 description 2
YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
238000011282 treatment Methods 0.000 description 2
NCNJDKUHZSYVPY-UHFFFAOYSA-N 11-oxo-8-propylpyrido[2,1-b]quinazoline-2-carboxylic acid Chemical compound C1=C(C(O)=O)C=C2C(=O)N(C=C(CCC)C=C3)C3=NC2=C1 NCNJDKUHZSYVPY-UHFFFAOYSA-N 0.000 description 1
LJLDNNWLODQKDV-UHFFFAOYSA-N 2-bromo-8-methylpyrido[2,1-b]quinazolin-11-one Chemical compound C1=C(Br)C=C2C(=O)N(C=C(C)C=C3)C3=NC2=C1 LJLDNNWLODQKDV-UHFFFAOYSA-N 0.000 description 1
VXLYOURCUVQYLN-UHFFFAOYSA-N 2-chloro-5-methylpyridine Chemical compound CC1=CC=C(Cl)N=C1 VXLYOURCUVQYLN-UHFFFAOYSA-N 0.000 description 1
YMDNODNLFSHHCV-UHFFFAOYSA-N 2-chloro-n,n-diethylethanamine Chemical compound CCN(CC)CCCl YMDNODNLFSHHCV-UHFFFAOYSA-N 0.000 description 1
OKDGRDCXVWSXDC-UHFFFAOYSA-N 2-chloropyridine Chemical compound ClC1=CC=CC=N1 OKDGRDCXVWSXDC-UHFFFAOYSA-N 0.000 description 1
BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
UAWMVMPAYRWUFX-UHFFFAOYSA-N 6-Chloronicotinic acid Chemical compound OC(=O)C1=CC=C(Cl)N=C1 UAWMVMPAYRWUFX-UHFFFAOYSA-N 0.000 description 1
ULHLOQZZZWIQSC-UHFFFAOYSA-N 6-butyl-11-oxopyrido[2,1-b]quinazoline-2-carboxylic acid Chemical compound C1=C(C(O)=O)C=C2C(=O)N3C=CC=C(CCCC)C3=NC2=C1 ULHLOQZZZWIQSC-UHFFFAOYSA-N 0.000 description 1
FMEBIWNKYZUWFV-UHFFFAOYSA-N 6-chloropyridine-3-carbonyl chloride Chemical compound ClC(=O)C1=CC=C(Cl)N=C1 FMEBIWNKYZUWFV-UHFFFAOYSA-N 0.000 description 1
QZHGBXHFHCJYHW-UHFFFAOYSA-N 6-ethyl-11-oxopyrido[2,1-b]quinazoline-2-carboxylic acid Chemical compound C1=C(C(O)=O)C=C2C(=O)N3C=CC=C(CC)C3=NC2=C1 QZHGBXHFHCJYHW-UHFFFAOYSA-N 0.000 description 1
IGKOVSKFILKPLY-UHFFFAOYSA-N 6-methyl-11-oxopyrido[2,1-b]quinazoline-2-carboxylic acid Chemical compound C1=C(C(O)=O)C=C2C(=O)N3C=CC=C(C)C3=NC2=C1 IGKOVSKFILKPLY-UHFFFAOYSA-N 0.000 description 1
MYIWXUFJMAMOTO-UHFFFAOYSA-N 8-butyl-11-oxopyrido[2,1-b]quinazoline-2-carboxylic acid Chemical compound C1=C(C(O)=O)C=C2C(=O)N(C=C(CCCC)C=C3)C3=NC2=C1 MYIWXUFJMAMOTO-UHFFFAOYSA-N 0.000 description 1
206010002198 Anaphylactic reaction Diseases 0.000 description 1
COXVTLYNGOIATD-HVMBLDELSA-N CC1=C(C=CC(=C1)C1=CC(C)=C(C=C1)\N=N\C1=C(O)C2=C(N)C(=CC(=C2C=C1)S(O)(=O)=O)S(O)(=O)=O)\N=N\C1=CC=C2C(=CC(=C(N)C2=C1O)S(O)(=O)=O)S(O)(=O)=O Chemical compound CC1=C(C=CC(=C1)C1=CC(C)=C(C=C1)\N=N\C1=C(O)C2=C(N)C(=CC(=C2C=C1)S(O)(=O)=O)S(O)(=O)=O)\N=N\C1=CC=C2C(=CC(=C(N)C2=C1O)S(O)(=O)=O)S(O)(=O)=O COXVTLYNGOIATD-HVMBLDELSA-N 0.000 description 1
ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
235000019739 Dicalciumphosphate Nutrition 0.000 description 1
PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
206010020751 Hypersensitivity Diseases 0.000 description 1
229910021578 Iron(III) chloride Inorganic materials 0.000 description 1
FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
229920000168 Microcrystalline cellulose Polymers 0.000 description 1
MBBZMMPHUWSWHV-BDVNFPICSA-N N-methylglucamine Chemical compound CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO MBBZMMPHUWSWHV-BDVNFPICSA-N 0.000 description 1
206010070834 Sensitisation Diseases 0.000 description 1
240000006394 Sorghum bicolor Species 0.000 description 1
MZVQCMJNVPIDEA-UHFFFAOYSA-N [CH2]CN(CC)CC Chemical group [CH2]CN(CC)CC MZVQCMJNVPIDEA-UHFFFAOYSA-N 0.000 description 1
UVSMPXZOOQOBDM-UHFFFAOYSA-N acetic acid;n,n-dimethylformamide;ethanol Chemical compound CCO.CC(O)=O.CN(C)C=O UVSMPXZOOQOBDM-UHFFFAOYSA-N 0.000 description 1
125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
150000007933 aliphatic carboxylic acids Chemical class 0.000 description 1
150000008044 alkali metal hydroxides Chemical class 0.000 description 1
229910001516 alkali metal iodide Inorganic materials 0.000 description 1
229910001860 alkaline earth metal hydroxide Inorganic materials 0.000 description 1
150000003973 alkyl amines Chemical class 0.000 description 1
125000005907 alkyl ester group Chemical group 0.000 description 1
150000001412 amines Chemical class 0.000 description 1
238000007098 aminolysis reaction Methods 0.000 description 1
235000019270 ammonium chloride Nutrition 0.000 description 1
239000000538 analytical sample Substances 0.000 description 1
230000036783 anaphylactic response Effects 0.000 description 1
208000003455 anaphylaxis Diseases 0.000 description 1
230000002804 anti-anaphylactic effect Effects 0.000 description 1
239000000043 antiallergic agent Substances 0.000 description 1
RQPZNWPYLFFXCP-UHFFFAOYSA-L barium dihydroxide Chemical compound [OH-].[OH-].[Ba+2] RQPZNWPYLFFXCP-UHFFFAOYSA-L 0.000 description 1
229910001863 barium hydroxide Inorganic materials 0.000 description 1
230000015572 biosynthetic process Effects 0.000 description 1
239000001045 blue dye Substances 0.000 description 1
239000012267 brine Substances 0.000 description 1
ACBDNFPUXYGKPT-UHFFFAOYSA-N bromomethyl 2,2-dimethylpropanoate Chemical compound CC(C)(C)C(=O)OCBr ACBDNFPUXYGKPT-UHFFFAOYSA-N 0.000 description 1
239000000872 buffer Substances 0.000 description 1
125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
239000001506 calcium phosphate Substances 0.000 description 1
239000000378 calcium silicate Substances 0.000 description 1
229910052918 calcium silicate Inorganic materials 0.000 description 1
235000012241 calcium silicate Nutrition 0.000 description 1
CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
239000008116 calcium stearate Substances 0.000 description 1
235000013539 calcium stearate Nutrition 0.000 description 1
OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
239000007963 capsule composition Substances 0.000 description 1
150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
239000003054 catalyst Substances 0.000 description 1
230000003197 catalytic effect Effects 0.000 description 1
239000003610 charcoal Substances 0.000 description 1
239000003153 chemical reaction reagent Substances 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
239000000460 chlorine Substances 0.000 description 1
229910052801 chlorine Inorganic materials 0.000 description 1
239000012230 colorless oil Substances 0.000 description 1
239000012059 conventional drug carrier Substances 0.000 description 1
238000000354 decomposition reaction Methods 0.000 description 1
NEFBYIFKOOEVPA-UHFFFAOYSA-K dicalcium phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O NEFBYIFKOOEVPA-UHFFFAOYSA-K 0.000 description 1
229940038472 dicalcium phosphate Drugs 0.000 description 1
229910000390 dicalcium phosphate Inorganic materials 0.000 description 1
HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 1
SBZXBUIDTXKZTM-UHFFFAOYSA-N diglyme Chemical compound COCCOCCOC SBZXBUIDTXKZTM-UHFFFAOYSA-N 0.000 description 1
238000001035 drying Methods 0.000 description 1
230000000694 effects Effects 0.000 description 1
ZKQFHRVKCYFVCN-UHFFFAOYSA-N ethoxyethane;hexane Chemical compound CCOCC.CCCCCC ZKQFHRVKCYFVCN-UHFFFAOYSA-N 0.000 description 1
OAYLNYINCPYISS-UHFFFAOYSA-N ethyl acetate;hexane Chemical compound CCCCCC.CCOC(C)=O OAYLNYINCPYISS-UHFFFAOYSA-N 0.000 description 1
125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
229960003699 evans blue Drugs 0.000 description 1
238000002474 experimental method Methods 0.000 description 1
229940032296 ferric chloride Drugs 0.000 description 1
229940044631 ferric chloride hexahydrate Drugs 0.000 description 1
229910052731 fluorine Inorganic materials 0.000 description 1
239000011737 fluorine Substances 0.000 description 1
125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 1
125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
125000001183 hydrocarbyl group Chemical group 0.000 description 1
XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
238000002347 injection Methods 0.000 description 1
239000007924 injection Substances 0.000 description 1
229910052500 inorganic mineral Inorganic materials 0.000 description 1
238000010253 intravenous injection Methods 0.000 description 1
INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 1
NQXWGWZJXJUMQB-UHFFFAOYSA-K iron trichloride hexahydrate Chemical compound O.O.O.O.O.O.[Cl-].Cl[Fe+]Cl NQXWGWZJXJUMQB-UHFFFAOYSA-K 0.000 description 1
125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
239000011777 magnesium Substances 0.000 description 1
229910052749 magnesium Inorganic materials 0.000 description 1
ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
239000001095 magnesium carbonate Substances 0.000 description 1
229910000021 magnesium carbonate Inorganic materials 0.000 description 1
235000014380 magnesium carbonate Nutrition 0.000 description 1
VXWPONVCMVLXBW-UHFFFAOYSA-M magnesium;carbanide;iodide Chemical compound [CH3-].[Mg+2].[I-] VXWPONVCMVLXBW-UHFFFAOYSA-M 0.000 description 1
239000000463 material Substances 0.000 description 1
238000005259 measurement Methods 0.000 description 1
229940098779 methanesulfonic acid Drugs 0.000 description 1
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
235000019813 microcrystalline cellulose Nutrition 0.000 description 1
239000008108 microcrystalline cellulose Substances 0.000 description 1
229940016286 microcrystalline cellulose Drugs 0.000 description 1
235000010755 mineral Nutrition 0.000 description 1
239000011707 mineral Substances 0.000 description 1
150000007522 mineralic acids Chemical class 0.000 description 1
QOHMWDJIBGVPIF-UHFFFAOYSA-N n',n'-diethylpropane-1,3-diamine Chemical compound CCN(CC)CCCN QOHMWDJIBGVPIF-UHFFFAOYSA-N 0.000 description 1
QAXZWHGWYSJAEI-UHFFFAOYSA-N n,n-dimethylformamide;ethanol Chemical compound CCO.CN(C)C=O QAXZWHGWYSJAEI-UHFFFAOYSA-N 0.000 description 1
APOAMYVLXQUECZ-UHFFFAOYSA-N n,n-dimethylformamide;ethanol;hydrochloride Chemical compound Cl.CCO.CN(C)C=O APOAMYVLXQUECZ-UHFFFAOYSA-N 0.000 description 1
125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
150000007524 organic acids Chemical class 0.000 description 1
MUMZUERVLWJKNR-UHFFFAOYSA-N oxoplatinum Chemical compound [Pt]=O MUMZUERVLWJKNR-UHFFFAOYSA-N 0.000 description 1
125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
UHZYTMXLRWXGPK-UHFFFAOYSA-N phosphorus pentachloride Chemical compound ClP(Cl)(Cl)(Cl)Cl UHZYTMXLRWXGPK-UHFFFAOYSA-N 0.000 description 1
229910003446 platinum oxide Inorganic materials 0.000 description 1
239000003880 polar aprotic solvent Substances 0.000 description 1
239000002798 polar solvent Substances 0.000 description 1
TZLVRPLSVNESQC-UHFFFAOYSA-N potassium azide Chemical compound [K+].[N-]=[N+]=[N-] TZLVRPLSVNESQC-UHFFFAOYSA-N 0.000 description 1
RPDAUEIUDPHABB-UHFFFAOYSA-N potassium ethoxide Chemical compound [K+].CC[O-] RPDAUEIUDPHABB-UHFFFAOYSA-N 0.000 description 1
238000003825 pressing Methods 0.000 description 1
125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 1
125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
NFRCNZHWCNHERP-UHFFFAOYSA-N pyrido[2,3-h]quinazoline Chemical compound N1=CN=C2C3=CC=CN=C3C=CC2=C1 NFRCNZHWCNHERP-UHFFFAOYSA-N 0.000 description 1
230000001105 regulatory effect Effects 0.000 description 1
229920006395 saturated elastomer Polymers 0.000 description 1
229930195734 saturated hydrocarbon Natural products 0.000 description 1
230000008313 sensitization Effects 0.000 description 1
239000011734 sodium Substances 0.000 description 1
229910052708 sodium Inorganic materials 0.000 description 1
239000011780 sodium chloride Substances 0.000 description 1
QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 1
235000009518 sodium iodide Nutrition 0.000 description 1
159000000000 sodium salts Chemical class 0.000 description 1
HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
230000001954 sterilising effect Effects 0.000 description 1
238000004659 sterilization and disinfection Methods 0.000 description 1
239000000126 substance Substances 0.000 description 1
235000012222 talc Nutrition 0.000 description 1
125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
238000011287 therapeutic dose Methods 0.000 description 1
YFNKIDBQEZZDLK-UHFFFAOYSA-N triglyme Chemical compound COCCOCCOCCOC YFNKIDBQEZZDLK-UHFFFAOYSA-N 0.000 description 1
230000002485 urinary effect Effects 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/49—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
- C07C205/57—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
- C07C205/59—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton the carbon skeleton being further substituted by singly-bound oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/61—Halogen atoms or nitro radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pulmonology (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Plural Heterocyclic Compounds (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

NO781051A 1977-03-24 1978-03-22 Kinazolinderivater. NO781051L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US78093977A	1977-03-24	1977-03-24
US87156478A	1978-01-23	1978-01-23

Publications (1)

Publication Number	Publication Date
NO781051L true NO781051L (no)	1978-09-26

Family

ID=27119777

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
NO781053A NO781053L (no)	1977-03-24	1978-03-22	Kinazolinderivater.
NO781051A NO781051L (no)	1977-03-24	1978-03-22	Kinazolinderivater.

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
NO781053A NO781053L (no)	1977-03-24	1978-03-22	Kinazolinderivater.

Country Status (23)

Country	Link
JP (2)	JPS53119897A (el)
AR (3)	AR218060A1 (el)
AT (2)	AT367050B (el)
AU (2)	AU521352B2 (el)
DE (2)	DE2812586A1 (el)
DK (2)	DK128878A (el)
ES (13)	ES468126A1 (el)
FI (2)	FI780917A7 (el)
FR (2)	FR2384771A1 (el)
GB (2)	GB1601991A (el)
GR (2)	GR72948B (el)
HU (1)	HU180782B (el)
IE (1)	IE46505B1 (el)
IL (2)	IL54326A (el)
IT (2)	IT1093710B (el)
LU (2)	LU79293A1 (el)
MC (2)	MC1185A1 (el)
NL (2)	NL7803122A (el)
NO (2)	NO781053L (el)
NZ (2)	NZ186760A (el)
PH (2)	PH13915A (el)
PT (2)	PT67820A (el)
SE (2)	SE7803419L (el)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2557425C2 (de)	1975-12-19	1987-03-19	C.H. Boehringer Sohn, 6507 Ingelheim	11-Oxo-11-H-pyrido[2,1-b]-chinazolin-2-carbonsäure und ihre Salze, Verfahren zu ihrer Herstellung und Arzneimittel
DE2845766A1 (de) *	1978-10-18	1980-04-30	Schering Ag	Pyrido eckige klammer auf 2,1-b eckige klammer zu -chinazolinon-derivate, ihre herstellung und verwendung
US4395549A (en)	1981-10-02	1983-07-26	Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt.	6-Hydrazono-pyrido[2,1-b] quinazoline-11 ones
ES8306729A1 (es) *	1982-04-30	1983-06-01	Lafarquim	"procedimiento de obtencion de 2-isopropil pirido (2-1-b) quinazolinas y sus sales no toxicas con actividad antianafilactica".
US4551460A (en) *	1982-05-10	1985-11-05	Hoffmann-La Roche Inc.	Pyrido[2,1-b]quinazoline derivatives useful as agents for treatment of allergic conditions and vascular disorders involving thrombosis
DE3300477A1 (de) *	1983-01-08	1984-07-12	Boehringer Ingelheim KG, 6507 Ingelheim	Neue heterocyclische verbindungen, ihre herstellung und verwendung
JPS62238264A (ja) *	1986-04-04	1987-10-19	Nippon Tokushu Noyaku Seizo Kk	２−ハロ−５−アセチルピリジン

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4012387A (en) *	1975-09-18	1977-03-15	Warner-Lambert Company	Benzo-[g]pyrido[2,1-b]quinazolinones
US4033961A (en) *	1975-10-07	1977-07-05	Warner-Lambert Company	Pyrido[2-1-b]quinazolin-ones and their methods of preparation

1978
- 1978-03-22 IL IL54326A patent/IL54326A/xx unknown
- 1978-03-22 NL NL7803122A patent/NL7803122A/xx not_active Application Discontinuation
- 1978-03-22 DK DK128878A patent/DK128878A/da not_active Application Discontinuation
- 1978-03-22 IL IL54328A patent/IL54328A/xx unknown
- 1978-03-22 NO NO781053A patent/NO781053L/no unknown
- 1978-03-22 MC MC781291A patent/MC1185A1/fr unknown
- 1978-03-22 ES ES468126A patent/ES468126A1/es not_active Expired
- 1978-03-22 LU LU79293A patent/LU79293A1/de unknown
- 1978-03-22 FR FR7808317A patent/FR2384771A1/fr active Granted
- 1978-03-22 DE DE19782812586 patent/DE2812586A1/de not_active Withdrawn
- 1978-03-22 LU LU79290A patent/LU79290A1/de unknown
- 1978-03-22 NZ NZ186760A patent/NZ186760A/xx unknown
- 1978-03-22 DK DK132778A patent/DK132778A/da not_active IP Right Cessation
- 1978-03-22 PH PH20917A patent/PH13915A/en unknown
- 1978-03-22 PH PH20918A patent/PH14130A/en unknown
- 1978-03-22 HU HU78HO2058A patent/HU180782B/hu unknown
- 1978-03-22 DE DE19782812585 patent/DE2812585A1/de not_active Withdrawn
- 1978-03-22 NO NO781051A patent/NO781051L/no unknown
- 1978-03-22 ES ES468127A patent/ES468127A1/es not_active Expired
- 1978-03-22 NZ NZ186759A patent/NZ186759A/xx unknown
- 1978-03-22 MC MC781292A patent/MC1186A1/fr unknown
- 1978-03-22 FR FR7808316A patent/FR2384770A1/fr active Granted
- 1978-03-22 NL NL7803112A patent/NL7803112A/xx not_active Application Discontinuation
- 1978-03-23 IT IT7821578A patent/IT1093710B/it active
- 1978-03-23 AT AT0210278A patent/AT367050B/de not_active IP Right Cessation
- 1978-03-23 GR GR55781A patent/GR72948B/el unknown
- 1978-03-23 GB GB11705/78A patent/GB1601991A/en not_active Expired
- 1978-03-23 PT PT67820A patent/PT67820A/pt unknown
- 1978-03-23 AU AU34474/78A patent/AU521352B2/en not_active Expired
- 1978-03-23 IE IE582/78A patent/IE46505B1/en unknown
- 1978-03-23 GB GB11704/78A patent/GB1601371A/en not_active Expired
- 1978-03-23 GR GR55782A patent/GR73170B/el unknown
- 1978-03-23 PT PT67821A patent/PT67821B/pt unknown
- 1978-03-23 AT AT0210478A patent/AT367051B/de not_active IP Right Cessation
- 1978-03-23 SE SE7803419A patent/SE7803419L/xx unknown
- 1978-03-23 AU AU34475/78A patent/AU521096B2/en not_active Expired
- 1978-03-23 FI FI780917A patent/FI780917A7/fi not_active Application Discontinuation
- 1978-03-23 SE SE7803418A patent/SE7803418L/xx unknown
- 1978-03-23 FI FI780918A patent/FI780918A7/fi not_active Application Discontinuation
- 1978-03-24 JP JP3400278A patent/JPS53119897A/ja active Pending
- 1978-03-24 IT IT21655/78A patent/IT1095493B/it active
- 1978-03-24 JP JP3320578A patent/JPS53119896A/ja active Pending
- 1978-03-27 AR AR271538A patent/AR218060A1/es active
- 1978-03-27 AR AR271537A patent/AR218480A1/es active
1979
- 1979-02-16 ES ES478331A patent/ES478331A1/es not_active Expired
- 1979-02-16 ES ES478327A patent/ES478327A1/es not_active Expired
- 1979-02-16 ES ES478329A patent/ES478329A1/es not_active Expired
- 1979-02-16 ES ES478332A patent/ES478332A1/es not_active Expired
- 1979-02-16 ES ES478325A patent/ES478325A1/es not_active Expired
- 1979-02-16 ES ES478323A patent/ES478323A1/es not_active Expired
- 1979-02-16 ES ES478324A patent/ES478324A1/es not_active Expired
- 1979-02-16 ES ES478330A patent/ES478330A1/es not_active Expired
- 1979-02-16 ES ES478328A patent/ES478328A1/es not_active Expired
- 1979-02-16 ES ES478333A patent/ES478333A1/es not_active Expired
- 1979-02-16 ES ES478326A patent/ES478326A1/es not_active Expired
- 1979-05-10 AR AR276467A patent/AR225415A1/es active

Also Published As

Publication number	Publication date
IL54328A (en)	1982-03-31
IL54326A (en)	1982-04-30
MC1186A1 (fr)	1978-12-22
NL7803122A (nl)	1978-09-26
IT7821578A0 (it)	1978-03-23
ES478330A1 (es)	1979-11-01
NO781053L (no)	1978-09-26
FR2384770A1 (fr)	1978-10-20
LU79293A1 (de)	1979-05-25
AU521096B2 (en)	1982-03-18
IE46505B1 (en)	1983-06-29
GR72948B (el)	1984-01-17
DK132778A (da)	1978-09-25
IE780582L (en)	1978-09-24
SE7803418L (sv)	1978-09-25
ES478329A1 (es)	1979-11-01
DK128878A (da)	1978-09-25
DE2812585A1 (de)	1978-09-28
HU180782B (en)	1983-04-29
ES478331A1 (es)	1979-11-16
PT67821B (en)	1980-03-04
ES478326A1 (es)	1979-11-01
ES478325A1 (es)	1979-11-01
ATA210278A (de)	1981-10-15
MC1185A1 (fr)	1978-12-22
FI780918A7 (fi)	1978-09-25
JPS53119897A (en)	1978-10-19
ES478333A1 (es)	1979-11-16
FR2384771B1 (el)	1980-04-04
ES478324A1 (es)	1979-11-01
GR73170B (el)	1983-02-14
PH14130A (en)	1981-02-26
ATA210478A (de)	1981-10-15
FI780917A7 (fi)	1978-09-25
ES478327A1 (es)	1979-11-01
GB1601371A (en)	1981-10-28
ES478323A1 (es)	1979-11-01
SE7803419L (sv)	1978-09-25
AT367051B (de)	1982-05-25
NL7803112A (nl)	1978-09-26
ES468127A1 (es)	1979-09-16
AU3447478A (en)	1979-09-27
ES478328A1 (es)	1979-11-01
AU521352B2 (en)	1982-04-01
IT1095493B (it)	1985-08-10
AR218480A1 (es)	1980-06-13
IL54326A0 (en)	1978-06-15
PT67820A (en)	1978-04-01
DE2812586A1 (de)	1978-09-28
IL54328A0 (en)	1978-06-15
ES478332A1 (es)	1979-11-16
IT7821655A0 (it)	1978-03-24
NZ186760A (en)	1981-03-16
AR225415A1 (es)	1982-03-31
ES468126A1 (es)	1979-09-01
IT1093710B (it)	1985-07-26
NZ186759A (en)	1981-03-16
PH13915A (en)	1980-11-04
FR2384771A1 (fr)	1978-10-20
AR218060A1 (es)	1980-05-15
LU79290A1 (de)	1979-05-25
PT67821A (en)	1978-04-01
AT367050B (de)	1982-05-25
AU3447578A (en)	1979-09-27
FR2384770B1 (el)	1980-10-24
JPS53119896A (en)	1978-10-19
GB1601991A (en)	1981-11-04

Publication	Publication Date	Title
US4880810A (en)	1989-11-14	Quinazolinediones and pyridopyrimidinediones
US4734418A (en)	1988-03-29	Quinazoline compounds and antihypertensives
CA2036618C (en)	2002-10-29	Fused thiophene derivatives, their production and use
WO1992022533A1 (en)	1992-12-23	4-aminoquinolines and pharmaceutical compositions thereof
NO151320B (no)	1984-12-10	Analogifremgangsmaate for fremstilling av terapeutisk aktiv pyrrolidylmetyl-2-metoksy-4-amino-5-isopropyl-sulfonylbenzamider
US4244950A (en)	1981-01-13	Derivatives of 4-amino-3-sulfonamido-pyridine, their preparation and use
CA2173876C (en)	2005-09-27	Alkoxy alkyl carbamates from imidazo(1,2-a)pyridines
US4332809A (en)	1982-06-01	Pyridinecarboxamide derivatives and process for the preparation thereof
US5223513A (en)	1993-06-29	Quinoline derivatives, their production and use
MXPA06014249A (es)	2007-02-19	Derivados de quinazolinona utiles como antagonistas vanilloides.
EP0011142B1 (de)	1982-12-29	Pyrido (2,1-b) chinazolinon-Derivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Präparate
MXPA06014337A (es)	2007-02-19	Derivados de cromona utiles como antagonistas vanilloides.
NO781051L (no)	1978-09-26	Kinazolinderivater.
EP0203435B1 (en)	1990-08-29	Novel pyridine derivatives and process for preparing the same
US4628055A (en)	1986-12-09	Method for treating allergic reactions and compositions therefore
US4348396A (en)	1982-09-07	Substituted 11-oxo-11H-pyrido[2,1-b]quinazolines and method of inhibiting allergic reactions with them
US4209620A (en)	1980-06-24	Substituted 3-(1H-tetrazol-5-yl)-4H-pyrido[1,2-a]pyrimidin-4-one derivatives having antiallergy activity
US4124587A (en)	1978-11-07	4-Hydroxy-3-sulfinyl-quinolin-2(1H)-ones
US4797403A (en)	1989-01-10	Quinazolinediones and pyridopyrimidinediones
US4758559A (en)	1988-07-19	Pyrrolo[1,2-a] [4,1]benzoxazepine derivatives useful as calmodulin and histamine inhibitors
US4192944A (en)	1980-03-11	Optionally substituted 4-oxo-4H-pyrido[1,2-a]pyrimidine-3-N-(1H-tetrazol-4-yl)carboxamides and their use as antiallergy agents
US4420476A (en)	1983-12-13	Benzofuro[3,2-c]pyrazol-3-amine derivatives
US4333937A (en)	1982-06-08	2-(Piperazinyl)-4-pyrimioinamines
RU2178785C2 (ru)	2002-01-27	Способ получения n-[2-(диметиламино)-этил]акридин-4-карбоксамида и его производных
CA2196076A1 (en)	1996-02-08	Acyl imidazopyridines